CTNNB1 and metabolic disease: S. Shimada et al. classified this type of cancer into three subtypes based on a comprehensive molecular evaluation and clinical features: (1) mitogenic, (2) CTNNB1-mutated, and (3) metabolic disease-associated tumors [25].